BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $622 from $561 and keeps a Buy rating on the shares after its Q4 earnings beat. The company’s System sales and procedure growth Y/Y meaningfully exceeded the Street’s high expectations by 58 units and 170bps respectively, and the Dv5 installed base now stands at 362 units, up 174 units from 188 in Q3, and continuing to accelerate even before a broader launch, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $707 from $690 at Baird
- Intuitive Surgical price target raised to $670 from $538 at Piper Sandler
- Intuitive Surgical price target raised to $675 from $575 at JPMorgan
- Intuitive Surgical price target raised to $711 from $640 at Citi
- ISRG Earnings: Intuitive Surgical Stock Drops Despite Q4 Beat
Questions or Comments about the article? Write to editor@tipranks.com